Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs. Our international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval.A combination of scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development. Scendea has team members based in the UK, the Netherlands, and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements.At Scendea we collaborate, innovate, and together with our clients, we succeed.

On the 1st June 2020 CNS was rebranded to Scendea